This appointment holds a bit more to it than regular partner commentary. Why is she really employed, straight after the trials fully enrolled, straight after Bio week, straight after a US based senior addition? What has happened that warrants a full time employee? The trial is now running on its own and the next phase is fully in play. Company making I believe.
I think its now clear that whoever wins inflammation control wins dmd. Hopefully we get what we know its worth.
Ann: Deborah Ambrosini appointed as CFO & Company Secretary, page-14
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
